TABLE 1.
Sequence no. | Region | Sequence |
---|---|---|
1 | 52-59 | SWFTALTQa |
2 | 69-75 | RGQGVPI |
3 | 83-89 | DQIGYYRa |
4 | 106-115 | SPRWYFYYLG |
5 | 118-124 | PEASLPY |
6 | 130-136 | GIVWVAT |
7 | 156-166 | AATVLQLPQGTa |
8 | 218-227 | TALALLLLDRa |
9 | 229-237 | NQLESKVSG |
10 | 243-249 | QGQTVTK |
11 | 267-273 | KQYNVTQ |
12 | 299-315 | YKHWPQIAQFAPSASAF |
13 | 323-339 | MEVTPSGTWLTYHGAIK |
14 | 347-363 | FKDNVILLNKHIDAYKTa |
15 | 379-385 | EAQPLPQa |
16 | 389-398 | KQPTVTLLPAa |
Predicted antigenic sequences corresponding to the immunodominant sites that were identified by Pepscan analysis.